Publications

5600 Results

Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma: A Southwest Oncology Group study.

Authors
RB Vance;JJ Crowley;JS Macdonald;FR Ahmann
Journal / Conference
IND 9(1):73-75
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8567

Treatment of limited small cell lung cancer with concurrent VP-16/cisplatin radiotherapy followed by intensification with high-dose cyclophosphamide. A Southwest Oncology Group study.

Authors
GE Goodman;J Crowley;RB Livingston;SE Rivkin;K Albain;JH McCulloch
Journal / Conference
JCO 9(3):453-457
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8573

Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study.

Authors
T Brown;P Goodman;T Fleming;S Taylor;J Macdonald
Journal / Conference
IND 9:113-114
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8622

A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.

Authors
CS Higano;J Crowley;RB Livingston;JW Goodwin;B Barlogie;WJ Stuckey
Journal / Conference
Cancer 57(1):2439-2442
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8625

Phase II study of pibenzimol in pancreatic cancer. A Southwest Oncology Group study.

Authors
EH Kraut;T Fleming;M Segal;JA Neidhart;BC Behrens;J Macdonald
Journal / Conference
IND 9:95-96
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8800

Long-term survival and toxicity in small cell lung cancer: Expanded Southwest Oncology Group experience.

Authors
KS Albain;JJ Crowley;RB Livingston
Journal / Conference
Chest 99:1425-1432
Year
1991

Adjuvant combination chemotherapy (CMFVP) vs oophorectomy followed by CMFVP (OCMFVP) for postmenopausal women with ER+ operable breast cancer with positive (+) axillary lymph nodes: An Intergroup study.

Authors
S Rivkin;S Green;B Metch;A Cruz;D Tesh;J Glick;W Knight;CK Osborne
Journal / Conference
ASCO 10:47(#64)
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Megesterol acetate (MA) and aminoglutethimide/hydrocortisone (AG) in sequence or in combination as second-line endocrine therapy of estrogen receptor positive metastatic breast cancer: A Southwest Oncology Group study.

Authors
J Congdon;S Green;J O'Sullivan;HE Hynes;R Belt;K Gail;B Zidar;CK Osborne
Journal / Conference
ASCO 10:43(#45)
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8312

Intergroup esophageal study: Comparison of radiotherapy to radio-chemotherapy combination: A phase III trial.

Authors
A Herskovic;K Martz;M Al-Sarraf;L Leichman;JS Brindle;VK Vaitkevicius;J Cooper;R Byhardt;L Davis;B Emami
Journal / Conference
ASCO 10:135(#407)
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8598

A phase III trial of recombinant human interferon-gamma (IFN) as adjuvant therapy of high risk malignant melanoma (MM).

Authors
FL Meyskens;K Kopecky;M Samson;D Noyes;R Tuthill;E Hersh;J Macdonald;H Jaffe;J Crowley;C Coltman, Jr
Journal / Conference
ASCO 10:291(#1019)
Year
1991
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8642